Advertisement

Topics

Impax Laboratories, Inc. (IPXL) Expected to Announce Quarterly Sales of $198.42 Million

05:13 EST 15 Nov 2017 | Topix

Brokerages predict that Impax Laboratories, Inc. will announce $198.42 million in sales for the current quarter, Zacks Investment Research reports. Four analysts have issued estimates for Impax Laboratories' earnings, with the lowest sales estimate coming in at $192.52 million and the highest estimate coming in at $204.30 million.

Original Article: Impax Laboratories, Inc. (IPXL) Expected to Announce Quarterly Sales of $198.42 Million

NEXT ARTICLE

More From BioPortfolio on "Impax Laboratories, Inc. (IPXL) Expected to Announce Quarterly Sales of $198.42 Million"

Quick Search
Advertisement
 

Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...